Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$87.44 - $112.11 $66,454 - $85,203
-760 Reduced 38.0%
1,240 $138,000
Q3 2022

Nov 07, 2022

BUY
$84.53 - $94.96 $2,535 - $2,848
30 Added 1.52%
2,000 $172,000
Q2 2022

Aug 02, 2022

BUY
$83.49 - $94.64 $135,253 - $153,316
1,620 Added 462.86%
1,970 $180,000
Q1 2022

May 04, 2022

SELL
$73.51 - $82.4 $24,993 - $28,016
-340 Reduced 49.28%
350 $29,000
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $49,873 - $62,472
690 New
690 $53,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Portfolio

Follow Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.